Eloot Sunny, Van Biesen Wim, Axelsen Mette, Glorieux Griet, Pedersen Robert Smith, Heaf James Goya
Department of Nephrology, Ghent University Hospital, De Pintelaan 185, 9000, Ghent, Belgium.
Institute of Public Health, Aarhus University, Nordre Ringgade 1, 8000, Aarhus C, Denmark.
BMC Nephrol. 2015 Apr 18;16:57. doi: 10.1186/s12882-015-0056-y.
Multipass hemodialysis (MPHD) is a recently described dialysis modality, involving the use of small volumes of dialysate which are repetitively recycled. Dialysis regimes of 8 hours for six days a week using this device result in an increased removal of small water soluble solutes and middle molecules compared to standard hemodialysis (SHD). Since protein-bound solutes (PBS) exert important pathophysiological effects, we investigated whether MPHD results in improved removal of PBS as well.
A cross-over study (Clinical Trial NCT01267760) was performed in nine stable HD patients. At midweek a single dialysis session was performed with either 4 hours SHD using a dialysate flow of 500 mL/min or 8 hours MPHD with a dialysate volume of 50% of estimated body water volume. Blood and dialysate samples were taken every hour to determine concentrations of p-cresylglucuronide (PCG), hippuric acid (HA), indole acetic acid (IAA), indoxyl sulfate (IS), and p-cresylsulfate (PCS). Dialyser extraction ratio, reduction ratio, and solute removal were calculated for these solutes.
Already at 60 min after dialysis start, the extraction ratio in the hemodialyser was a factor 1.4-4 lower with MPHD versus SHD, resulting in significantly smaller reduction ratios and lower solute removal within a single session. Even when extrapolating our findings to 3 times 4 h SHD and 6 times 8 h MPHD per week, the latter modality was at best similar in terms of total solute removal for most protein-bound solutes, and worse for the highly protein-bound solutes IS and PCS. When efficiency was calculated as solute removal/litre of dialysate used, MPHD was found superior to SHD.
When high water consumption is a concern, a treatment regimen of 6 times/week 8 h MPHD might be an alternative for 3 times/week 4 h SHD, but at the expense of a lower total solute removal of highly protein-bound solutes.
多次通过血液透析(MPHD)是一种最近描述的透析方式,涉及使用少量透析液进行重复循环。与标准血液透析(SHD)相比,使用该设备每周进行6天、每次8小时的透析方案可增加对小水溶性溶质和中分子的清除。由于蛋白质结合溶质(PBS)具有重要的病理生理作用,我们研究了MPHD是否也能改善对PBS的清除。
对9名稳定的血液透析患者进行了一项交叉研究(临床试验编号NCT01267760)。在一周中间,进行一次透析治疗,要么采用4小时的标准血液透析,透析液流速为500毫升/分钟,要么采用8小时的多次通过血液透析,透析液体积为估计身体水量的50%。每小时采集血液和透析液样本,以测定对甲酚葡萄糖醛酸(PCG)、马尿酸(HA)、吲哚乙酸(IAA)、硫酸吲哚酚(IS)和对甲酚硫酸盐(PCS)的浓度。计算这些溶质的透析器提取率、降低率和溶质清除率。
在透析开始后60分钟,与标准血液透析相比,多次通过血液透析在血液透析器中的提取率低1.4至4倍,导致单次治疗期间的降低率显著更小,溶质清除更低。即使将我们的研究结果外推至每周3次4小时的标准血液透析和6次8小时的多次通过血液透析,对于大多数蛋白质结合溶质,后一种方式在总溶质清除方面充其量相似,而对于高度蛋白质结合的溶质IS和PCS则更差。当以每升使用的透析液的溶质清除率计算效率时,发现多次通过血液透析优于标准血液透析。
当高耗水量成为一个问题时,每周6次、每次8小时的多次通过血液透析治疗方案可能是每周3次、每次4小时的标准血液透析的替代方案,但代价是高度蛋白质结合溶质的总溶质清除率较低。